These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 15939500)

  • 1. Pluronic block copolymers alter apoptotic signal transduction of doxorubicin in drug-resistant cancer cells.
    Minko T; Batrakova EV; Li S; Li Y; Pakunlu RI; Alakhov VY; Kabanov AV
    J Control Release; 2005 Jul; 105(3):269-78. PubMed ID: 15939500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of monensin liposomes on the cytotoxicity, apoptosis and expression of multidrug resistance genes in doxorubicin-resistant human breast tumour (MCF-7/dox) cell-line.
    Shaik MS; Chatterjee A; Singh M
    J Pharm Pharmacol; 2004 Jul; 56(7):899-907. PubMed ID: 15233869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of MDR development in leukemia cells by micelle-forming polymeric surfactant.
    Sharma AK; Zhang L; Li S; Kelly DL; Alakhov VY; Batrakova EV; Kabanov AV
    J Control Release; 2008 Nov; 131(3):220-7. PubMed ID: 18722489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of pluronic and doxorubicin on drug uptake, cellular metabolism, apoptosis and tumor inhibition in animal models of MDR cancers.
    Batrakova EV; Li S; Brynskikh AM; Sharma AK; Li Y; Boska M; Gong N; Mosley RL; Alakhov VY; Gendelman HE; Kabanov AV
    J Control Release; 2010 May; 143(3):290-301. PubMed ID: 20074598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alteration of genomic responses to doxorubicin and prevention of MDR in breast cancer cells by a polymer excipient: pluronic P85.
    Batrakova EV; Kelly DL; Li S; Li Y; Yang Z; Xiao L; Alakhova DY; Sherman S; Alakhov VY; Kabanov AV
    Mol Pharm; 2006; 3(2):113-23. PubMed ID: 16579640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of multidrug resistance by methoxypolyethylene glycol-block-polycaprolactone diblock copolymers through the inhibition of P-glycoprotein function.
    Elamanchili P; McEachern C; Burt H
    J Pharm Sci; 2009 Mar; 98(3):945-58. PubMed ID: 18623213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fundamental relationships between the composition of pluronic block copolymers and their hypersensitization effect in MDR cancer cells.
    Batrakova E; Lee S; Li S; Venne A; Alakhov V; Kabanov A
    Pharm Res; 1999 Sep; 16(9):1373-9. PubMed ID: 10496652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parthenolide reverses doxorubicin resistance in human lung carcinoma A549 cells by attenuating NF-κB activation and HSP70 up-regulation.
    Xin Y; Yin F; Qi S; Shen L; Xu Y; Luo L; Lan L; Yin Z
    Toxicol Lett; 2013 Aug; 221(2):73-82. PubMed ID: 23792430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting Cellular Metabolism Chemosensitizes the Doxorubicin-Resistant Human Breast Adenocarcinoma Cells.
    Ma S; Jia R; Li D; Shen B
    Biomed Res Int; 2015; 2015():453986. PubMed ID: 26558272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pluronic P85 increases permeability of a broad spectrum of drugs in polarized BBMEC and Caco-2 cell monolayers.
    Batrakova EV; Li S; Miller DW; Kabanov AV
    Pharm Res; 1999 Sep; 16(9):1366-72. PubMed ID: 10496651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A P-glycoprotein- and MRP1-independent doxorubicin-resistant variant of the MCF-7 breast cancer cell line with defects in caspase-6, -7, -8, -9 and -10 activation pathways.
    Park SJ; Wu CH; Safa AR
    Anticancer Res; 2004; 24(1):123-31. PubMed ID: 15015586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear factor-κB signaling inhibitors revert multidrug-resistance in breast cancer cells.
    Abdin SM; Tolba MF; Zaher DM; Omar HA
    Chem Biol Interact; 2021 May; 340():109450. PubMed ID: 33775688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic action of doxorubicin and sulindac in human cervix carcinoma cells - studies on possible mechanisms.
    Gruber BM; Bubko I; Krzyszton-Russjan J; Anuszewska EL
    Med Sci Monit; 2010 Jan; 16(1):BR45-51. PubMed ID: 20037485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal effect of isotetrandrine, an isoquinoline alkaloid extracted from Caulis Mahoniae, on P-glycoprotein-mediated doxorubicin-resistance in human breast cancer (MCF-7/DOX) cells.
    Wang TX; Yang XH
    Yao Xue Xue Bao; 2008 May; 43(5):461-6. PubMed ID: 18717331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An essential relationship between ATP depletion and chemosensitizing activity of Pluronic block copolymers.
    Kabanov AV; Batrakova EV; Alakhov VY
    J Control Release; 2003 Aug; 91(1-2):75-83. PubMed ID: 12932639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal of cancer multidrug resistance by green tea polyphenols.
    Mei Y; Qian F; Wei D; Liu J
    J Pharm Pharmacol; 2004 Oct; 56(10):1307-14. PubMed ID: 15482646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gambogic acid sensitizes resistant breast cancer cells to doxorubicin through inhibiting P-glycoprotein and suppressing survivin expression.
    Wang S; Wang L; Chen M; Wang Y
    Chem Biol Interact; 2015 Jun; 235():76-84. PubMed ID: 25824409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanoparticle-directed sub-cellular localization of doxorubicin and the sensitization breast cancer cells by circumventing GST-mediated drug resistance.
    Zeng X; Morgenstern R; Nyström AM
    Biomaterials; 2014 Jan; 35(4):1227-39. PubMed ID: 24210875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA.
    Liu ZL; Onda K; Tanaka S; Toma T; Hirano T; Oka K
    Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, characterization, antitumor activity of pluronic mimicking copolymer micelles conjugated with doxorubicin via acid-cleavable linkage.
    Lee Y; Park SY; Mok H; Park TG
    Bioconjug Chem; 2008 Feb; 19(2):525-31. PubMed ID: 18163537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.